WASHINGTON – The Japanese nuclear crisis has reignited a debate in the U.S. over the government's role in distributing a cheap anti-cancer drug to people living around nuclear power plants.
The Nuclear Regulatory Commission currently makes the drug, potassium iodide, available to states for...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.